Waverly Advisors LLC Purchases 2,064 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Waverly Advisors LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 11,799 shares of the medical equipment provider’s stock after purchasing an additional 2,064 shares during the quarter. Waverly Advisors LLC’s holdings in Intuitive Surgical were worth $6,159,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at about $26,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Down 0.8%

ISRG opened at $557.16 on Wednesday. The company has a market cap of $199.70 billion, a price-to-earnings ratio of 86.92, a PEG ratio of 5.85 and a beta of 1.70. The company’s 50 day moving average is $508.11 and its 200 day moving average is $537.36. Intuitive Surgical, Inc. has a 12-month low of $396.15 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the firm posted $1.50 earnings per share. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $566.94, for a total transaction of $106,584.72. Following the transaction, the chief financial officer now owns 7,162 shares of the company’s stock, valued at $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at $205,093. This represents a 87.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,700 shares of company stock valued at $16,865,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ISRG shares. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.